Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New York, New York–(Newsfile Corp. – January 18, 2025) – WHY: Rosen Law Firm, a global investment law firm, reminds clients of Nextracker Inc.’s common stock. (NASDAQ: NXT) between February 1, 2024 and August 1, 2024, both dates inclusive (the “Class Period”), is relevant. February 25, 2025 is the time to lead the plaintiff.
NOW: If you purchased Nextracker common stock during the Class Period, you may be entitled to receive compensation without paying fees or expenses through the contingency fee arrangement.
WHAT YOU NEED TO DO: To join the Nextracker class action, go to https://rosenlegal.com/submit-form/?case_id=32936 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action. A class action lawsuit has been filed. If you wish to act as a lead plaintiff, you must relocate Court before March 25, 2025. The lead plaintiff is the party representing the other members of the class to conduct the case.
WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Oftentimes, the companies that issue the notices don’t have the experience, the resources, or any meaningful peer recognition. Most of these firms do not litigate securities class actions, but are simply brokers who refer clients or partner with law firms that litigate the cases. Be smart when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder litigation. The Rosen Law Firm achieved the largest defense settlement against a Chinese Company at that time. Rosen Law Firm is ranked No. 1 is the ISS Securities Group Action (WA:) Securities ranking services in 2017. The firm has been ranked 4th every year since 2013 and has earned hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Most of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.
FACTS OF THE CASE: According to the lawsuit, throughout the Class Period, the defendants made false and misleading statements and/or failed to disclose that: (1) the effect of project delays on Nextracker’s business, financial results, and prospects were much stronger than those represented to investors; (2) approval and connection delays had impaired Nextracker’s ability to convert traffic into revenue at old conversion rates; (3) Nextracker was unable to offset the adverse effect of project delays through increased customer demand and the implied ability to advance its other projects in the manner represented by defendants; (4) Nextracker did not have the competitive advantages that allegedly protected it from industry-wide headwinds or the ability to offset the adverse effects of project delays as alleged by defendants; and (5) as a result of the above, the defendants lacked a reasonable basis for their positive statements about Nextracker’s business, financial results, and prospects. When the real facts entered the market, the lawsuit alleges that investors were harmed.
To join the Nextracker class action, go to https://rosenlegal.com/submit-form/?case_id=32936 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action.
No Group Guaranteed. Until the group is confirmed, you are not represented by a counselor unless you have reserved one. You can choose a consultant of your choice. You can remain a member of the missing group and do nothing at this point. The investor’s ability to contribute to future recovery does not depend on serving as the primary plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https: / /www.facebook.com/rosenlawfirm/.
Advertising Attorney. Preliminary results do not guarantee a similar outcome.
——————————
Contact information:
To view the source version of this release, please visit https://www.newsfilecorp.com/release/237711